Neonatal Fc receptor (FcRn) antagonists offer new opportunities for personalized care for patients with generalized myasthenia gravis (gMG) through their targeted mechanism of action, varied routes of administration, and flexible dosing schedules. With three FcRn antagonists now available, are you fully prepared to integrate these therapies into your practice? Through this interactive Clinical Case Challenge, test your skills in the application of FcRn antagonists, receive instant feedback from a gMG expert on your responses to real-world scenarios, and access downloadable evidence addressing: The safety and efficacy of FcRn antagonists in gMG Patient characteristics that guide FcRn antagonist selection Approaches to developing individualized treatment plans
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Case study / clinical scenario
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedNov 24, 2025
-
Last day to claim creditNov 24, 2026 6 weeks left
-
PVI, PeerView Institute for Medical Education Redefining Treatment Pathways in Generalized Myasthenia Gravis: Strengthening Clinician Expertise in Diagnosis and Personalized Care With FcRn Antagonists
-
DrBeen Corp H2 Receptor Antagonists (PM 9)
-
CME Outfitters, LLC Rethinking Suppression: GnRH Antagonists and Contemporary Endometriosis Management
-
PRIME Education, Inc. (PRIME®) Quick Take: FcRn Antagonists and Their Practical Role in gMG Care
-
PRIME Education, Inc. (PRIME®) Myasthenia Gravis Beyond the Acetylcholine Receptor: Treatment Options, Emerging Evidence, and Individualized Care
-
PRIME Education, Inc. (PRIME®) Strategies for Personalized CIDP Care: Patient Selection, Treatment Transition, and FcRn Therapy
